IP Verse

Pfizer Products competitive analysis

Loading summary...

Latest patents of Pfizer Products opposed by its competitors

Explore Pfizer Products's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2134702
Aug 30, 2023Crystalline Forms Of 6-[2-(Methylcarbamoyl)Phenylsulfanyl]-3-E-[2-(Pyridin-2-Yl)Ethenyl]Indazole Suitable For The Treatment Of Abnormal Cell Growth In Mammals1

Latest publications and patents of Pfizer Products New

Explore the latest publications and patents granted to Pfizer Products, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Pfizer Products

EP2134702
Aug 30, 2023Crystalline Forms Of 6-[2-(Methylcarbamoyl)Phenylsulfanyl]-3-E-[2-(Pyridin-2-Yl)Ethenyl]Indazole Suitable For The Treatment Of Abnormal Cell Growth In MammalsPatent Maintained As Amended

Latest PTAB cases involving Pfizer Products

Discover the latest PTAB cases involving Pfizer Products, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Pfizer Products with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
PFIZER PRODUCTS - 1 - -
TEVA PHARMACEUTICALS20916 - 12